(4-(ethylamino)-2-(methylthio)pyrimidin-5-yl)methanol, 97%, 5g

1-Hydroxy-2-naphthaldehyde, 98.0%, 1g

3-Iodo-2-methylbenzonitrile, 98%, 25g

Bis(tri-tert-butylphosphine)palladium(0)>98.0%(T)1g

Difurfuryl Sulfide>98.0%(GC)25g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-phenylbutanoic acid, 97%, 5g

2-Methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid, 95.0%, 5g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(thiazol-4-yl)propanoic acid, 95.0%, 25g

2-Chloro-1-(2-ethoxyethyl)-1H-benzo[d]imidazole, 95.0%, 5g

3-amino-N-(4-methylphenyl)benzamide, 95.0%, 1g

Plan phase PLPHi 10x/0.25 infinity corrected IOS objective. Working distance 5.00 mm

N-[2-Nitro-4-(trifluoromethyl)phenyl]morpholine, 1g

Methyl 2-tert-Butyloxycarbonylaminoacrylate, 95.0%, 1g